Aldrink Jennifer H, Cost Nicholas G, McLeod Daryl J, Bates David Gregory, Stanek Joseph R, Smith Ethan A, Ehrlich Peter F
Division of Pediatric Surgery, Department of Surgery, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio.
Division of Pediatric Urology, Department of Surgery, Children's Hospital Colorado, University of Colorado, Aurora, Colorado.
J Surg Res. 2018 Dec;232:614-620. doi: 10.1016/j.jss.2018.07.022. Epub 2018 Aug 9.
Chemotherapy is used preoperatively for children with bilateral Wilms tumor (BWT) or unilateral high-risk Wilms tumor (UHRWT) to promote tumor regression to facilitate renal preservation with nephron-sparing surgery (NSS). In adults, various surgical techniques have been described to preserve renal tissue. Few studies have examined the use of surgical adjuncts in NSS in children with renal tumors.
We performed a multi-institutional retrospective review of patients with BWT or UHRWT. Patient demographics, tumor size at diagnosis, following neoadjuvant chemotherapy, utilization of surgical adjuncts including intraoperative ultrasound (IOUS), margin status, complications, renal function, and follow-up were recorded.
The cohort comprised 23 patients: 18 BWT, 3 UHRWT, and 2 patients with solitary kidney. Twenty-two of the 23 patients had successful NSS. IOUS was used 19 times, and seven had positive margins after surgery. Cooling/vascular isolation was used six times. At a median follow-up of 18 mo, median estimated glomerular filtration rate Schwartz was 126 mL/min/1.73 m and median serum creatinine 0.39 mg/dL in the 22 patients who had successful NSS. There have been no tumor recurrences.
In patients with BWT and UHRWT, surgical adjuncts such as cooling/vascular isolation are uncommonly performed. IOUS may be helpful but does not guarantee negative microscopic margins.
Level 4, Case series with no comparison group.
化疗用于双侧肾母细胞瘤(BWT)或单侧高危肾母细胞瘤(UHRWT)患儿的术前治疗,以促进肿瘤消退,便于通过保留肾单位手术(NSS)保留肾脏。在成人中,已描述了多种保留肾组织的手术技术。很少有研究探讨肾肿瘤患儿NSS中手术辅助手段的应用。
我们对BWT或UHRWT患者进行了多机构回顾性研究。记录患者的人口统计学资料、诊断时肿瘤大小、新辅助化疗后的情况、包括术中超声(IOUS)在内的手术辅助手段的使用情况、切缘状态、并发症、肾功能及随访情况。
该队列包括23例患者:18例BWT、3例UHRWT和2例单肾患者。23例患者中有22例成功进行了NSS。IOUS使用了19次,7例术后切缘阳性。冷却/血管隔离使用了6次。在中位随访18个月时,22例成功进行NSS的患者中,中位估计肾小球滤过率Schwartz为126 mL/min/1.73m²,中位血清肌酐为0.39mg/dL。无肿瘤复发。
在BWT和UHRWT患者中,冷却/血管隔离等手术辅助手段很少使用。IOUS可能有帮助,但不能保证显微镜下切缘阴性。
4级,无对照组的病例系列。